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Recent studies have suggested that Rap1 and Rap2 small GTP-binding proteins are both expressed in human red blood cells (RBCs). In
this work, we carefully examined the expression of Rap proteins in leukocytes- and platelets-depleted RBCs, whose purity was established
on the basis of the selective expression of the β2 subunit of the Na+/K+-ATPase, as verified according to the recently proposed “β-profiling
test” [J.F. Hoffman, A. Wickrema, O. Potapova, M. Milanick, D.R. Yingst, Na pump isoforms in human erythroid progenitor cells and
mature erythrocytes, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14572-14577]. In pure RBCs preparations, Rap2, but not Rap1 was detected
immunologically. RT-PCR analysis of mRNA extracted from highly purified reticulocytes confirmed the expression of Rap2b, but not
Rap2a, Rap2c, Rap1a or Rap1b. In RBCs, Rap2 was membrane-associated and was rapidly activated upon treatment with Ca2+/Ca2+-
ionophore. In addition, Rap2 segregated and was selectively enriched into microvesicles released by Ca2+-activated RBCs, suggesting a
possible role for this GTPase in membrane shedding.
© 2006 Elsevier B.V. All rights reserved.Keywords: Red blood cells; Rap1; Rap2; Small GTPases; Vesiculation1. Introduction
Rap proteins define a family of highly homologous small
GTP-binding proteins, which includes five members, Rap1a,
Rap1b, Rap2a, Rap2b, and the recently discovered Rap2c,
which are grouped into two subfamilies, Rap1 and Rap2,
based on the high sequence homology [1,2]. Like other
small GTPases, Rap proteins function as molecular switches,
as they are activated by exchange of GDP for GTP and
inactivated through GTP hydrolysis stimulated by GTPase-
Activating Proteins (GAP). Many physiological agonists are
able to activate Rap proteins in a number of cell types,
through the stimulation of exchange factors regulated by⁎ Corresponding author. Tel.: +39 0382 987238; fax: +39 0382 987240.
E-mail address: mtorti@unipv.it (M. Torti).
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doi:10.1016/j.bbamcr.2006.02.001cAMP, Ca2+, or tyrosine kinases [3]. Rap proteins represent
important regulators of fundamental cellular functions, such
as adhesion, secretion and vesicle trafficking [4,5]. In
particular Rap1, but also Rap2 proteins have been
recognized to mediate integrin activation and to regulate
integrin-dependent cell adhesion [5]. In addition, different
studies have suggested the involvement of Rap proteins in
intracellular vesicle trafficking and release [6,7]. Rap
proteins are widely expressed, but the relative amount of
individual members may vary considerably, depending on
the tissue or cell type considered. Among circulating cells,
members of both Rap1 and Rap2 subfamilies have been
found to be abundant in platelets and leukocytes [1].
Several small GTP-binding proteins have also been
identified in red blood cells (RBCs), including RhoA and
members of the Arf, Rab, and Ral families [8–11]. Recently,
two independent studies based on proteomic approaches
have reported the expression of both Rap1a and Rap1b in
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to the Rap-specific cAMP-sensitive guanine nucleotides
exchange factor, EPAC, Rap1 proteins have been proposed
to mediate sickle cell adhesion to laminin [14].
Analysis of protein expression in RBCs is often compro-
mised by contaminating leukocytes and, to a lesser extent,
platelets. The level of contaminating cells and their impact on
the measurements performed is not always taken in due
consideration. Recently, it has been demonstrated that RBCs
are unique among circulating cells, as they express exclusively
the β2 subunit isoform of the Na+-pump, while leukocytes and
platelets possess the β1 isoform [15]. The analysis of the β
subunit expression profile (the so-called β-profiling) represents
an excellent and definitive method to evaluate the purity of
RBCs preparations [16].
By combining a cellulose-based method for RBCs
purification, which allows efficient removal of contaminating
cells, and a β-profiling analysis, we obtained highly purified
RBCs, and we demonstrated that, in contrast to previously
reported findings, Rap2, but not Rap1, is expressed in
RBCs. Moreover, we found that this protein can be activated
by GTP binding in RBCs treated with Ca2+ and Ca2+
ionophore, and segregates into the vesicles released by
RBCs in a Ca2+-dependent manner.
2. Materials and methods
2.1. Cell preparation
Blood was collected from healthy volunteers using 0.1 volume of 3.8% (w/
v) tri-sodium citrate as anticoagulant. RBCs were recovered by centrifugation
and further purified from leukocytes and platelets by filtration through cellulose,
as described [17]. Subpopulations of RBCs of different age were prepared as
detailed elsewhere [18]. Mononuclear cells (MNC) were isolated by
Lympholite-H (Cedarlane, Hornby, Ontario, Canada) according to manufac-
turer's instructions. Human platelets were prepared from blood withdrawn in 0.1
volume of ACD (152 mM sodium citrate, 130 mM citric acid, 112 mM glucose).
Platelet rich plasma was obtained by centrifugation at 120×g for 10 min, and
platelets were then purified by gel-filtration on Sepharose 2B, as previously
described [19].
2.2. Stimulation of red blood cells with Ca2+ and vesicles preparation
Purified RBCs at 3–5% hematocrit in HEPES buffer (5 mM HEPES,
150 mM NaCl, 2 mM MgCl2, 5 mM glucose, pH 7.4, containing 0.2 mM
phenyl-methyl-sulfonyl-fluoride (PMSF), 5 μg/ml aprotinin, 50 μg/ml
leupeptin), were incubated at 37 °C in the presence of 0.3 mM CaCl2
and 4 μM calcium–ionophore A23187 for various times as specified.
Vesicles released during 20 min incubation were isolated and purified as
previously detailed [18]. Purified ghost membranes were prepared by
hypotonic lysis of RBCs in 5 mM phosphate buffer, pH 8.0, containing
0.2 mM PMSF at 4 °C according to the method of Dodge et al. [20].
Cholesterol was assayed in RBCs ghost membranes and vesicles using a
colorimetric assay kit (R-Biopharm Italia Srl, Milan, Italy).
2.3. RT-PCR analysis
RNA was extracted from reticulocytes present in RBCs preparations and
fromMNC using TRIzol reagent (Invitrogen Life Technology, Paisley, Scotland,
UK), according to the supplier's recommendations. First strand cDNA was
synthesized from 1 μg of total RNA using the High Capacity cDNA Archive Kit
(Applera, Woolston, Warrington Cheshire, UK), according to manufacturer'sinstructions. Beta-profiling assay was performed using primers for β1 and β2
subunits of the human Na+/K+ ATPase, and RT-PCR conditions as described by

















Reactions were cycled 40 times through the following program: the
denaturation (94 °C for 1 min) was followed by the annealing (55 °C for 45 s),
and the extension (72 °C for 45 s). To verify the specificity of the primers used,
parallel PCR reactions were performed using as templates pET-16b/rap1a, pET-
16b/rap1b, pET-16b/rap2a, pET-16b/rap2b¸ pET-16b/rap2c. The products of
the PCR reaction were separated on 1.5% agarose gels and visualized with
ethidium bromide.
2.4. Immunoblotting analysis
Samples of total RBCs were lysed as previously described [18], and
aliquots corresponding to a given number of cells (specified in the figures)
were separated by SDS-PAGE on 10–20% acrylamide gradient gels, and
transferred to nitrocellulose. When RBCs ghosts were subjected to SDS-
PAGE, they were also loaded on the basis of ghost membrane number or
based on cholesterol content. Immunoblotting analysis was performed with
anti-Rap1 and anti-Rap2 polyclonal antibodies (Santa Cruz Biotechnology,
Tebu-Bio, Magenta, Italy) (1:1.000 dilution), essentially as previously
described [19].
2.5. Rap2 activation assay
Activation of Rap2 was evaluated by a pull-down assay using purified
recombinant GST-tagged Rap-binding domain of RalGDS (GST-RalGDS-RBD)
to precipitate GTP-bound Rap proteins from a cell lysate, as described [21].
Precipitated, active Rap2 was then separated by SDS-PAGE on a 10–20%
acrylamide gradient gel, transferred to nitrocellulose, and identified by
immunoblotting with the specific polyclonal antibody.
3. Results and discussion
3.1. Rap2, but not Rap1 proteins are expressed in highly
purified human red blood cells
Analysis of protein expression in human RBCs is often
hampered by the presence of contaminating leukocytes and
platelets, which may produce misleading results. Among the
several techniques currently used to prepare isolated RBCs,
filtration through cellulose has been proven to represent the most
efficient strategy to significantly lower the level of contaminat-
ing cells. We prepared highly purified RBCs by filtration
through cellulose in order to investigate the expression of
different Rap proteins family members in these circulating cells.
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this technique, revealed that contaminant leukocytes and
platelets were less than 0.002% and 0.02%, respectively. The
purity of the RBCs preparation was further demonstrated by the
β-profiling test, as recently proposed by Hoffman and co-
workers [15, 16]. This powerful and definitive test exploits the
fact that platelets and leukocytes, but not RBCs, express the
mRNA for the β1 isoform subunit of the Na+/K+-ATPase, while
the β2 isoform is exclusively expressed in RBCs but neither in
leukocytes nor in platelets. Fig. 1A shows that mRNA for β2,
but not β1 could be detected in RBCs, while the opposite was
observed in purified MNC, thus confirming the high purity of
our RBCs preparations. Based on the data from the β-profiling
test, we confidently analyzed the expression of mRNA for the
different Rap proteins. While all the five known Rap proteinsFig. 1. Rap2, but not Rap1, is expressed in human RBCs. (A) β-profiling analysis o
prepared by filtration through cellulose, and containing about 1% reticulocytes, as wel
to PCR amplification using pairs of primers for β1 and β2 isoforms of the β subunit o
Products of amplification were identified after separation in 1.5% agarose gel and ethid
using primers for Rap1a, Rap1b, Rap2a, Rap2b, and Rap2c, as indicated on the top. In
with the cDNA for the corresponding protein in pET-16b, C(+). As positive control
indicated. (C) Proteins from 2×107 gel filtered platelets (PLT tot), from 107RBCs prep
(met. ref. [12]) and by Kakhniashvili et al. [13] (met. ref. [13]) (iii), as well as membr
(from F1 to F6) (ii) were separated in a 10–20% acrylamide gradient gel, transferred to
Rap1 proteins (lower panel). Note that the different lanes in panel (ii) correspond to
Similarly, the amount of total RBCs loaded in the lanes shown in panels (i) and (iii)were expressed in purifiedMNC, only the mRNA for Rap2b, but
not that for Rap2a, Rap2c, Rap1a or Rap1b was present in highly
purified RBCs (Fig. 1B).
The different expression of Rap proteins family members
in RBCs was then investigated by immunoblotting. Current-
ly available antibodies are able to discriminate between
Rap1 and Rap2 proteins, but cannot distinguished among
the highly homologous members within each subfamily. Fig.
1C(i) shows that, as previously reported [1], both Rap1 and
Rap2 proteins are expressed in human platelets. In lysates of
highly purified RBCs, however, only Rap2, but not Rap1,
proteins were detected immunologically. In the light of the
results from RT-PCR analysis, we may reasonably conclude
that the Rap2 protein detected in RBCs by immunoblotting
is most likely Rap2b.f purified RBCs. Total RNAwas extracted from a suspension of RBCs (RBCs)
l as from purifiedMNC (MNC). First stranded cDNAwas prepared and subjected
f Na+/K+-ATPase, as well as β-actin, as a positive control, as indicated on the top.
ium bromide staining. (B) RT-PCRwas performed of cDNA fromRBCs orMNC
any reaction, primers were also tested with buffer, as negative control, C(−), and
s, RT-PCR reactions were performed with primers for GAPDH and β-actin, as
ared by filtration through cellulose (RBCs tot) (i) or as described by Low et al. [12]
ane proteins from 5×107 RBCs of various subpopulations of increasing cell age
nitrocellulose and probed with antibodies against Rap2 proteins (upper panel) or
an identical amount of cells (5×107) derived from the same RBCs preparation.
are identical (107).
Fig. 2. Rap2 is membrane associated and segregates into vesicles released by
Ca2+-loaded RBCs. (A) RBCs were fractionated into membrane (ghost) and
cytosolic (cytosol) fractions. Membrane skeleton was isolated from RBCs upon
lysis with 2% Triton X-100, as detergent-insoluble materials (Triton insoluble)
and separated from solubilized membrane components (Triton soluble) by
centrifugation [18]. The distribution of Rap2 among these cellular fractions was
analysed by immunoblotting with the specific antibody. In each lane, an
equivalent of 107 RBCs was loaded. (B) A sample of purified RCBs was treated
with 0.3 mM Ca2+/4 μM A23187 (final concentrations) at 3% hematocrit in
HEPES buffer. At the different times indicated in the figure, aliquots containing
108 cells were withdrawn from the RBCs suspension and lysed. Active, GTP-
bound Rap2 was precipitated using GST-RalGDS-RBD, and identified by
immunoblotting with a specific antibody. (C) Quantification of Rap2 enrichment
in vesicles vs ghosts. Equal amounts of cholesterol (4 μg) for ghosts (ghost) and
vesicles (ves) were loaded on a 10–20% acrylamide gradient gel, transferred to
nitrocellulose and immunoblotted with anti-Rap2 antibody. For accurate
quantification, an amount of vesicles corresponding to 1/3 of ghosts, in terms
of cholesterol, was also loaded (ves 1/3), resulting in an integrated area
approximately similar for ghosts and vesicles. The blot shown is representative
of four independent experiments giving similar results. (D) The Rap2
enrichment factor in vesicles vs. ghosts was measured from the integrated
area of Rap2-positive bands as described above, and was found to be: 2.90±0.58
(n=4).
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lation of cells of different age, and it has been previously
reported that the protein endowment of these cells may be age-
dependent. Therefore, by density-based fractionation of the
purified RBCs, we separately analyzed Rap proteins expression
in RBCs of different ages, which were prepared and
characterized as previously described [18]. As shown in Fig.
1C(ii), Rap2 was found to be expressed in cells of different age,
while Rap1 was never detected, even if, in these studies,
proteins from a number of RBCs 5-fold higher than that
analyzed in the experiments reported in Fig. 1C(i) (107 cells)
were loaded on the gel. These observations definitively exclude
the possibility of a selective expression of Rap1 in a
subpopulation of RBCs, particularly in light/young subpopula-
tions, which are highly enriched in reticulocytes.
Recently, two independent groups have reported detection of
Rap1 in human RBCs [12,13]. In these studies, however, the
blood samples were not subjected to rigorous leukodepletion,
therefore a certain degree of contamination by white cells and
platelets could have affected the RBCs population. In order to
investigate whether the previously reported expression of Rap1
protein in RBCs was an artifact due to contaminating leukocytes
and platelets, we prepared RBCs according to the procedure
used by Low et al. [12], or by Kakhniashvili et al. [13]. By
hemocytometer-based cell counting, we found that, in both
RBC preparations, contamination by leukocytes and platelets
resulted to be about 0.03% and 0.08%, respectively, thus much
higher than that measured in RBCs prepared by filtration
through cellulose (0.002% leukocytes and 0.02% platelets, see
above). Immunoblotting analysis performed on proteins derived
from an identical number of RBCs as shown in Fig. 1C(i) (107)
revealed that not only Rap2, but also Rap1 was actually
detectable in RBCs prepared according to Low et al. [12], or by
Kakhniashvili et al. [13] (Fig. 1C (iii)). These results confirm
the validity of the filtration through cellulose as a suitable and
recommendable method for RBCs preparation. In addition, we
can confidently conclude that Rap2, presumably Rap2b, but not
Rap1, is expressed in RBCs, and that the previously reported
expression of Rap1 proteins, based on proteomic studies, was to
be ascribed to contaminating cells.
Rap1 has been recently proposed to promote sickle RBCs
adhesion to laminin, thus implying its expression in these cells
[14]. In that study, contaminating leukocytes were lowered to
0.01% by immunomagnetic depletion, but were still 5-fold
higher than in our preparations. Moreover, the expression of
Rap1 was not directly documented by immunoblotting or RT-
PCR analysis, but, rather, deduced on the basis of a functional
test showing that active, GTP-bound Rap1 could be precipitated
from the RBCs preparation. Although it may sound reasonable
to assume that the detection of the active form of the protein
implies the expression of the protein itself, the approach is
rather unusual, and, certainly, not as reliable as the direct
detection of the protein or its mRNA. It cannot be excluded, for
instance, that when mixed with RBCs, the low contaminant
leukocytes produce enough active Rap1 to allow detection upon
precipitation from a large volume of cell suspension. However,
it should be considered that sickle cells often show an alteredpattern of protein expression than normal RBCs [22], and, thus,
it is still possible that in these cells, Rap1 is expressed and
regulates cell adhesion, as proposed.
3.2. Rap2 is activated in human red blood cells and segregates
into released vesicles
We next investigated the subcellular distribution and
activation of Rap2 in human RBCs. Cells were fractionated
into membranes (ghost) and cytosol. Moreover, cells were
treated with Triton X-100 in order to isolate the membrane
skeleton as detergent-insoluble fraction. Immunoblotting
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predominantly associated to the plasma membrane, but did not
reveal a stable interaction with the membrane-skeleton (Fig.
2A). In circulating platelets, Rap2 can be activated in response
to many physiological agonists through signaling pathways
largely dependent on intracellular Ca2+ increase [21]. We found
that treatment of RBCs with Ca2+/A23187 induced a rapid and
sustained increase of GTP binding to Rap2, which was evident
after 30 s and maximal after 1 min (Fig. 2B). This indicates that
Rap2 in RBCs can be regulated by Ca2+-dependent exchange
factors. It is known that treatment of RBCs with Ca2+/A23187
induces the release of microvesicles. In vivo, membrane
vesiculation is associated with RBC aging, and may have
important physiological consequences, as released vesicles
carry pro-coagulant activities [23,24]. RBCs were treated with
Ca2+/A23187, and the released vesicles were isolated. By
immunoblotting analysis, we found that Rap2 segregated into
microvesicles released from Ca2+-treated RBCs. When the
amount of Rap2 in RBCs and vesicles was normalized to the
level of membrane cholesterol, which is equally represented,
relative to total lipids, in the membrane of cells and vesicles
[25], we measured that Rap2 was about 3-fold enriched in the
released vesicles. Similar levels of enrichment are known only
for the GPI-linked proteins of the erythrocyte membrane.
Therefore, inclusion of Rap2 into the released vesicles is not
merely a passive process due to membrane shedding, but
reflects a specific segregation of this protein. Using the pull-
down assay with GST-RalGDS-RBD, no active GTP-bound
Rap2 was detected into the released vesicles (data not shown).
This is probably due to the hydrolysis of the bound GTP by the
intrinsic GTPase activity of Rap2 during the rather long time
required to isolate the released vesicles, but it may also suggest
that inclusion of Rap2 into the shedding vesicle is associated
with the hydrolysis of protein-bound GTP.
3.3. Conclusions
In conclusion, by adopting the recently proposed “β-
profiling” method as a screen to establish the purity of RBCs
preparations, we have reported clear and definitive evidence
that, in contrast to previous observations, Rap2, most likely
Rap2b, is the only Rap protein expressed in human RBCs, and
that Rap1 proteins are not present. Our study, therefore,
recommends caution in the choice of the procedure used for
RBCs preparation, and confirms the validity of the filtration
through cellulose as a valuable, cheap, and reliable method to
lower the amount of contaminating leukocytes to undetectable
levels. Moreover, we have provided evidence that Rap2 can be
activated in RBCs, and is selectively enriched in microvesicles
released from Ca2+-treated RBCs, thus suggesting its possible
involvement in membrane shedding.
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